Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings, and welcome to the Amphastar Pharmaceuticals, Inc. Second Quarter Earnings Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. Please note that certain statements made during this call regarding matters that are not historical facts, including, but not limited to, management's outlook or predictions for future periods are forward looking statements. These statements are based solely on information that is now available to us. We encourage you to review the session entitled Forward Looking Statements in the press release issued today and the presentation on the company's website. Also, please refer to our SEC filings, which can be found on the company's website and the SEC's website for a discussion of numerous factors that may impact our future performance. We will also discuss certain non GAAP measures. Important information on our use of these measures and reconciliations to U. S. GAAP may be found in our earnings release. Please note this conference is being recorded. Our speakers today are Mr. Bill Peters, CFO Mr. Dan Dishner, Senior Vice President, Corporate Communications and Mr. Tony Mars, Executive Vice President of Regulatory Affairs and Clinical Operations. I will now turn the conference over to your host, Mr. Dan Dishner, Senior Vice President of Corporate Communications. Dan, you may begin. Thank you, Paul. Good afternoon, everyone, and thank you for joining Amphastar's second quarter twenty twenty six earnings call. Earlier today, we reported the financial results for the second quarter ended 06/30/2026, which are available on the Investors page of our website. The second quarter was marked by strong execution across each of our strategic growth pillars. We observed...